These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 37349834)

  • 41. Critical Role of Novel O-GlcNAcylation of S550 and S551 on the p65 Subunit of NF-κB in Pancreatic Cancer.
    Motolani A; Martin M; Wang B; Jiang G; Alipourgivi F; Huang X; Safa A; Liu Y; Lu T
    Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835439
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lack of O-GlcNAcylation enhances exercise-dependent glucose utilization potentially through AMP-activated protein kinase activation in skeletal muscle.
    Murata K; Morino K; Ida S; Ohashi N; Lemecha M; Park SY; Ishikado A; Kume S; Choi CS; Sekine O; Ugi S; Maegawa H
    Biochem Biophys Res Commun; 2018 Jan; 495(2):2098-2104. PubMed ID: 29253568
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cross regulation between mTOR signaling and O-GlcNAcylation.
    Very N; Steenackers A; Dubuquoy C; Vermuse J; Dubuquoy L; Lefebvre T; El Yazidi-Belkoura I
    J Bioenerg Biomembr; 2018 Jun; 50(3):213-222. PubMed ID: 29524020
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sevoflurane postconditioning reduces myocardial ischemia reperfusion injury-induced necroptosis by up-regulation of OGT-mediated O-GlcNAcylated RIPK3.
    Zhang J; Yu P; Hua F; Hu Y; Xiao F; Liu Q; Huang D; Deng F; Wei G; Deng W; Ma J; Zhu W; Zhang J; Yu S
    Aging (Albany NY); 2020 Nov; 12(24):25452-25468. PubMed ID: 33231560
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chronic hyperglycemia induces tau hyperphosphorylation by downregulating OGT-involved O-GlcNAcylation in vivo and in vitro.
    Huang R; Tian S; Zhang H; Zhu W; Wang S
    Brain Res Bull; 2020 Mar; 156():76-85. PubMed ID: 31931119
    [TBL] [Abstract][Full Text] [Related]  

  • 46. O-GlcNAcylation disrupts STRA6-retinol signals in kidneys of diabetes.
    Chen CH; Lin KD; Ke LY; Liang CJ; Kuo WC; Lee MY; Lee YL; Hsiao PJ; Hsu CC; Shin SJ
    Biochim Biophys Acta Gen Subj; 2019 Jun; 1863(6):1059-1069. PubMed ID: 30905621
    [TBL] [Abstract][Full Text] [Related]  

  • 47. O-GlcNAc transferase is involved in glucocorticoid receptor-mediated transrepression.
    Li MD; Ruan HB; Singh JP; Zhao L; Zhao T; Azarhoush S; Wu J; Evans RM; Yang X
    J Biol Chem; 2012 Apr; 287(16):12904-12. PubMed ID: 22371499
    [TBL] [Abstract][Full Text] [Related]  

  • 48. OSMI-1 Enhances TRAIL-Induced Apoptosis through ER Stress and NF-κB Signaling in Colon Cancer Cells.
    Lee SJ; Lee DE; Choi SY; Kwon OS
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681736
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The interaction of O-GlcNAc-modified NLRX1 and IKK-α modulates IL-1β expression in M1 macrophages.
    Chen L; Li Y; Zeng S; Duan S; Huang Z; Liang Y
    In Vitro Cell Dev Biol Anim; 2022 May; 58(5):408-418. PubMed ID: 35513753
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cross-talk between two essential nutrient-sensitive enzymes: O-GlcNAc transferase (OGT) and AMP-activated protein kinase (AMPK).
    Bullen JW; Balsbaugh JL; Chanda D; Shabanowitz J; Hunt DF; Neumann D; Hart GW
    J Biol Chem; 2014 Apr; 289(15):10592-10606. PubMed ID: 24563466
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diverse metabolic effects of O-GlcNAcylation in the pancreas but limited effects in insulin-sensitive organs in mice.
    Ida S; Morino K; Sekine O; Ohashi N; Kume S; Chano T; Iwasaki K; Harada N; Inagaki N; Ugi S; Maegawa H
    Diabetologia; 2017 Sep; 60(9):1761-1769. PubMed ID: 28642969
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Schwann cell O-GlcNAcylation promotes peripheral nerve remyelination via attenuation of the AP-1 transcription factor JUN.
    Kim S; Maynard JC; Strickland A; Burlingame AL; Milbrandt J
    Proc Natl Acad Sci U S A; 2018 Jul; 115(31):8019-8024. PubMed ID: 30012597
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Polo-like kinase 1 (PLK1) O-GlcNAcylation is essential for dividing mammalian cells and inhibits uterine carcinoma.
    Yan S; Peng B; Kan S; Shao G; Xiahou Z; Tang X; Chen YX; Dong MQ; Liu X; Xu X; Li J
    J Biol Chem; 2023 Feb; 299(2):102887. PubMed ID: 36626982
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Glycaemia and body weight are regulated by sodium-glucose cotransporter 1 (SGLT1) expression via O-GlcNAcylation in the intestine.
    Nishimura K; Fujita Y; Ida S; Yanagimachi T; Ohashi N; Nishi K; Nishida A; Iwasaki Y; Morino K; Ugi S; Nishi E; Andoh A; Maegawa H
    Mol Metab; 2022 May; 59():101458. PubMed ID: 35189429
    [TBL] [Abstract][Full Text] [Related]  

  • 55. O-Linked β-N-Acetylglucosamine Modification of A20 Enhances the Inhibition of NF-κB (Nuclear Factor-κB) Activation and Elicits Vascular Protection After Acute Endoluminal Arterial Injury.
    Yao D; Xu L; Xu O; Li R; Chen M; Shen H; Zhu H; Zhang F; Yao D; Chen YF; Oparil S; Zhang Z; Gong K
    Arterioscler Thromb Vasc Biol; 2018 Jun; 38(6):1309-1320. PubMed ID: 29622561
    [TBL] [Abstract][Full Text] [Related]  

  • 56. O-GlcNAc transferase promotes fatty liver-associated liver cancer through inducing palmitic acid and activating endoplasmic reticulum stress.
    Xu W; Zhang X; Wu JL; Fu L; Liu K; Liu D; Chen GG; Lai PB; Wong N; Yu J
    J Hepatol; 2017 Aug; 67(2):310-320. PubMed ID: 28347804
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Suppressed OGT expression inhibits cell proliferation and modulates EGFR expression in renal cell carcinoma.
    Wang L; Chen S; Zhang J; Mao S; Mao W; Zhang W; Guo Y; Wu Y; Wang R; Yan Y; Yao X
    Cancer Manag Res; 2019; 11():2215-2223. PubMed ID: 30962710
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Feedback Regulation of
    Lin CH; Liao CC; Chen MY; Chou TY
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33801653
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Elevated O-GlcNAcylation promotes gastric cancer cells proliferation by modulating cell cycle related proteins and ERK 1/2 signaling.
    Jiang M; Qiu Z; Zhang S; Fan X; Cai X; Xu B; Li X; Zhou J; Zhang X; Chu Y; Wang W; Liang J; Horvath T; Yang X; Wu K; Nie Y; Fan D
    Oncotarget; 2016 Sep; 7(38):61390-61402. PubMed ID: 27542217
    [TBL] [Abstract][Full Text] [Related]  

  • 60. O-linked β-N-acetylglucosamine modification of proteins is essential for foot process maturation and survival in podocytes.
    Ono S; Kume S; Yasuda-Yamahara M; Yamahara K; Takeda N; Chin-Kanasaki M; Araki H; Sekine O; Yokoi H; Mukoyama M; Uzu T; Araki SI; Maegawa H
    Nephrol Dial Transplant; 2017 Sep; 32(9):1477-1487. PubMed ID: 28339907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.